Eppendorf SE: conversion to European public limited company

The internationally active life science company Eppendorf, headquartered in Hamburg, Germany, has completed its conversion to the European legal form Societas Europaea (SE) as of October 19, 2021.

"We are convinced that we have taken the right step at the right time with this modern legal form, which is very common in large family-owned companies," said Eva van Pelt and Dr. Peter Fruhstorfer, Co-CEOs of Eppendorf SE. "The company's name as a European public limited company is a clear signal that even more strongly expresses Eppendorf's global corporate culture. In addition, the new legal form shows that Eppendorf is an international company and that national borders play less and less of a role for us."

The company will operate as Eppendorf SE with immediate effect. Picture: © Eppendorf SE

The new company name as Eppendorf SE demonstrates the company's further development into a modern, progressive, and internationally active European company, the CEOs added. Also, it provides important support that will enable Eppendorf to continue its global success course even more effectively, they said.

The conversion into a Societas Europaea will not result in any changes to the company's structure. Management Board and Supervisory Board members continue to work for Eppendorf SE. Eppendorf's Group headquarters will remain in Hamburg, Germany, and the character of an independent familyowned company will be preserved.

More News

The large and lively “HALRIC family” gathered in Lund in February to recap the three amazing years of the project and look ahead to the future. (Photo: HALRIC)
The large and lively “HALRIC family” gathered in Lund in February to recap the three amazing years of the project and look ahead to the future. (Photo: HALRIC)

HALRIC Strengthens Life Science Connections in Northern Europe

After three years, Life Science Nord has issued a positive assessment of the Interreg project HALRIC – Hanseatic Life Science Research Infrastructure Consortium. The project’s ...

Read more …
Dr. Fernando Delgado (CTO), Dr. Michael Hartung (CPO), Alexander Zahn (CEO), and Prof. Dr. Jan Baumbach (CSO) (from left) founded the company in Hamburg in 2025. (Photo: Galagos)
Dr. Fernando Delgado (CTO), Dr. Michael Hartung (CPO), Alexander Zahn (CEO), and Prof. Dr. Jan Baumbach (CSO) (from left) founded the company in Hamburg in 2025. (Photo: Galagos)

#NEWatLSN: Galagos

We are delighted to welcome Galagos as a new member of Life Science Nord e.V.! The founding team answered questions about the company’s initial goals, ...

Read more …
The meetings brought together senior representatives from the European Commission and multiple Member States. (Picture: HALRIC)
The meetings brought together senior representatives from the European Commission and multiple Member States. (Picture: HALRIC)

HALRIC in Brussels

Through direct dialogue with the European Commission and Member States, HALRIC’s Brussels discussions showed how cross-border life science collaboration can unlock efficiency, strengthen European competitiveness, ...

Read more …